Medicare Enrolled

Dr. Shawn Carter, MD

Radiation Oncology · Tampa, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
3402 W DR MARTIN LUTHER KING JR BLVD, Tampa, FL 33607
8138753950
In practice since 2007 (18 years)
NPI: 1659582286 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Carter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Carter

Dr. Shawn Carter is a radiation oncology in Tampa, FL, with 18 years in practice. Based on federal Medicare data, Dr. Carter performed 111,111 Medicare services across 4,353 unique beneficiaries.

Between the years covered by Open Payments, Dr. Carter received a total of $2,747 from 7 pharmaceutical and/or device companies across 17 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Carter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 1% volume in FL$ $2,747 industry payments

Medicare Practice Summary

Medicare Utilization ↗
111,111
Medicare services
Top 1% in FL for radiation oncology
4,353
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,173 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging (iodine-based)106,222$0$1
Ct scan of chest with contrast1,080$85$549
CT scan of abdomen and pelvis with contrast963$238$889
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries873$402$680
Nuclear medicine study from skull base to mid-thigh with ct scan780$1,184$4,005
Piflufolastat f-18, diagnostic, 1 millicurie393$468$1,469
CT scan of chest, without contrast230$81$679
Nuclear medicine study whole body with ct scan154$1,182$4,007
Ct scan of abdomen and pelvis without contrast131$142$570
Copper cu-64, dotatate, diagnostic, 1 millicurie84$1,521$3,044
Ct scan of soft tissue of neck with contrast69$109$884
Ct scan of abdomen and pelvis before and after contrast31$270$1,112
Ct scan of abdomen with contrast29$179$970
Ct scan of chest before and after contrast22$100$1,094
Ct scan of abdomen before and after contrast19$182$1,094
Ct scan of blood vessels of chest with contrast17$188$1,245
Ct scan of head or brain before and after contrast14$118$916
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,747
Total received (2018-2024)
Avg $458/year across 6 years
Top 18% in FL for radiation oncology
7
Companies
17
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,012 (73.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$735 (26.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$101
2023
$28
2021
$908
2020
$1,200
2019
$238
2018
$273

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Blue Earth Diagnostics Limited
$2,446
Augmenix, Inc.
$137
GE HEALTHCARE
$66
Progenics Pharmaceuticals, Inc.
$30
Boston Scientific Corporation
$28
Siemens Medical Solutions USA, Inc.
$22
Astellas Pharma US Inc
$19
Top 3 companies account for 96.4% of total payments
Associated products mentioned in payments ›
Axumin · MYRBETRIQ · POSLUMA · PYLARIFY · Peripheral RotaLink Plus · Posluma · SpaceOAR
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (73%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $2 per 100 Medicare services performed
Looking for a radiation oncology in Tampa?
Compare radiation oncologys in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologys nearby

Geographic Context

Radiation Oncologys within 10 mi
375
Per 100K population
25.2
County median income
$75,011
Nearest hospital
ST JOSEPHS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Carter is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (consulting-driven, top 18%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Carter experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Carter performed 106,222 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Carter receive payments from pharmaceutical companies?
Yes. Dr. Carter received a total of $2,747 from 7 companies across 17 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carter's costs compare to other radiation oncologys in Tampa?
Dr. Carter's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →